Skip to menu Skip to content Skip to footer

2024

Journal Article

Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer

Yaghoubi Naei, Vahid, Ivanova, Ekaterina, Mullally, William, O'Leary, Connor G, Ladwa, Rahul, O'Byrne, Ken, Warkiani, Majid E and Kulasinghe, Arutha (2024). Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer. Clinical and Translational Immunology, 13 (6) e1516, e1516. doi: 10.1002/cti2.1516

Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer

2023

Journal Article

Liquid biopsy snapshots of key phosphoproteomic pathways in lung cancer patients for diagnosis and therapy monitoring

Ahmed, Mostak, Wuethrich, Alain, Constantin, Nicolas, Shanmugasundaram, Karthik Balaji, Mainwaring, Paul, Kulasinghe, Arutha, O’Leary, Connor, O’Byrne, Ken, Sina, Abu Ali Ibn, Carrascosa, Laura G. and Trau, Matt (2023). Liquid biopsy snapshots of key phosphoproteomic pathways in lung cancer patients for diagnosis and therapy monitoring. Analytical Chemistry, 95 (22), 8522-8532. doi: 10.1021/acs.analchem.3c00519

Liquid biopsy snapshots of key phosphoproteomic pathways in lung cancer patients for diagnosis and therapy monitoring

2022

Journal Article

Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer

Kapeleris, Joanna, Bark, Juliana Müller, Ranjit, Shanon, Irwin, Darryl, Hartel, Gunter, Warkiani, Majid Ebrahimi, Leo, Paul, O’Leary, Connor, Ladwa, Rahul, O'Byrne, Kenneth, Hughes, Brett G.M. and Punyadeera, Chamindie (2022). Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. Heliyon, 8 (7) e09971, 1-9. doi: 10.1016/j.heliyon.2022.e09971

Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer

2021

Journal Article

The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)

Kulasinghe, Arutha, O'Leary, Connor, Monkman, James, Bharti, Vandhana, Irwin, Darryl, Dutta, Sanjay, Richard, Derek J., Hughes, Brett, Ladwa, Rahul and O'Byrne, Ken (2021). The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC). Lung Cancer, 160, 73-77. doi: 10.1016/j.lungcan.2021.08.005

The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)

2020

Journal Article

High-plex and high-throughput digital spatial profiling of non-small-cell lung cancer (NSCLC)

Monkman, James, Taheri, Touraj, Warkiani, Majid Ebrahimi, O’leary, Connor, Ladwa, Rahul, Richard, Derek, O’ Byrne, Ken and Kulasinghe, Arutha (2020). High-plex and high-throughput digital spatial profiling of non-small-cell lung cancer (NSCLC). Cancers, 12 (12) 3551, 1-16. doi: 10.3390/cancers12123551

High-plex and high-throughput digital spatial profiling of non-small-cell lung cancer (NSCLC)

2020

Journal Article

Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the blood

Kulasinghe, Arutha, Monkman, James, Nalder, Mark, O’Leary, Connor, Ladwa, Rahul and O’Byrne, Ken (2020). Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the blood. Reports, 3 (4) 33, 33. doi: 10.3390/reports3040033

Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the blood

2020

Journal Article

Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer

Kapeleris, Joanna, Kulasinghe, Arutha, Warkiani, Majid Ebrahimi, Oleary, Connor, Vela, Ian, Leo, Paul, Sternes, Peter, O'Byrne, Kenneth and Punyadeera, Chamindie (2020). Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. Translational Lung Cancer Research, 9 (5), 1795-1809. doi: 10.21037/tlcr-20-521

Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer

2020

Journal Article

Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)

O’Leary, Connor, Gasper, Harry, Sahin, Katherine B., Tang, Ming, Kulasinghe, Arutha, Adams, Mark N., Richard, Derek J. and O’Byrne, Ken J. (2020). Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC). Pharmaceuticals, 13 (10) 273, 1-16. doi: 10.3390/ph13100273

Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)